期刊文献+

α-硫辛酸对帕金森病大鼠脑内多巴胺能神经元的保护作用及其机制探讨 被引量:3

To explore mechanism of theα-lipoic acid neuroprotection effect in Parkinson's rats induced by rotenone
下载PDF
导出
摘要 目的观察α-硫辛酸(LA)对鱼藤酮致帕金森(PD)大鼠模型黑质多巴胺能神经元的保护作用。方法健康成年雄性Wistar大鼠背部皮下注射鱼藤酮制备PD大鼠模型,药物治疗组同时给予大鼠腹腔注射LA。采用分光光度法检测大鼠脑内丙二醛(MDA)和还原型谷胱甘肽(GSH),Western blot检测大鼠中脑黑质及纹状体酪氨酸羟化酶(TH)的表达变化。结果与对照组相比,鱼藤酮组大鼠纹状体中MDA明显增高(P<0.01)而GSH含量明显降低(P<0.01),TH蛋白在黑质和纹状体与对照组比较明显降低(P<0.05);LA干预后与鱼藤酮组相比MDA明显降低及GSH明显增高(P<0.05),TH蛋白表达明显增加(P<0.05)。结论氧化应激在PD发病中起着非常重要的作用,LA能有效减轻PD大鼠脑内氧化应激损伤、保护脑内多巴胺能神经体系,同时改善PD样症状。 Objective To investigate the protect effect ofα-lipoic acid( LA) on the substantial nigra dopaminergic neuron in Parkinsons' rats induced by rotenone. Methods The healthy adult male Wistar rats were injected subcutaneously rotenone in back to prepare the PD rats model,the rats in drug therapy group were injected intraperitoneally LA at the same time. Spectrophotometry was used to detect oxidative stress parameters in rats( MDA and GSH),Westen blot was used to detect the changed expression of TH in the substantia nigra and striatum of rats. Results MDA was significantly increased( P 0. 01),and GSH was significantly decreased( P 0. 01) in the rats striatum of rotenone group than that in control group. The expression of TH was significantly decreased in the substantia nigra and striatum compared with control group( P 0. 05). MDA were obviously decreased and GSH were increased significantly after the intervention of LA compared with rotenone group( P 0. 05),TH protein was increased significantly( P 0. 05). Conclusions Oxidative stress plays a very important role in the pathogenesis of PD,LA can effectively reduce the injury of dopaminergic neurons in rat brain,improve the symptoms of PD at the same time.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2014年第5期419-421,共3页 Journal of Apoplexy and Nervous Diseases
关键词 帕金森病 多巴胺 Α-硫辛酸 氧化应激 Parkinson's disease Dopamine α-Lipoic acid Oxidative stress
  • 相关文献

参考文献9

  • 1Rochette L, Ghibu S, Richard C,et al. Direct and indirect antioxidant properties of ct-lipoic acid and therapeutic potential [J]. Mol Nutr Food Res ,2013,57 ( 1 ) : 114 - 25. 被引量:1
  • 2Bisaglia M, Greggio E, Behramini M, et al. Dysfunction of dopamine homeostasis:clues in the hunt for novel Parkinson' s disease therapies [J]. FASEBJ,2013,27(6):2101-210. 被引量:1
  • 3Hirsch EC. Future drug targets for Parkinson ' s disease [ J ]. Bull Acad Natl Med,2012,196(7) :1369 -1377. 被引量:1
  • 4Tolleson CM, Fang JY. Advances in the mechanisms of Parkinson' s disease [ J ]. Discov Med, 2013,15 ( 80 ) : 61 - 66. 被引量:1
  • 5Surmeier D J, Sulzer D. The pathology roadmap in Parkinson disease [ J] Prion,2013,7 ( 1 ) : 85 - 91. 被引量:1
  • 6Cannon JR, Tapias V, Na HM, et al. A highly reproducible rotenone model of Parkinson' s disease [ J 1. Neurobiol Dis, 2009,34 (2) : 279 - 290. 被引量:1
  • 7Xiong N, Huang J, Zhang Z, et al. Stereotaxical infusion of rotenone : a reliable rodent model for Parkinson' s disease[ J]. PLoS One,2009,4 (11) :e7878. 被引量:1
  • 8Houston MC. Role of mercury toxicity in hypertension, cardiovascular disease, and stroke [ J ]. J Clin Hypertens ( Greenwich ) , 2011,13 ( 8 ) : 621 - 627. 被引量:1
  • 9Pocernich CB,Lange ML, Sultana R, et al. Nutritional approaches to modulate oxidative stress in Alzheimer' s disease[ J]. Curr Alzheimer Res,2011,8 (5) :452 - 469. 被引量:1

同被引文献19

  • 1王蓉,欧阳敏,张萍,王琼.帕金森病小鼠黑质纹状体小胶质细胞活化表达的炎性因子与多巴胺含量的关系[J].中国老年学杂志,2014,34(10):2768-2770. 被引量:11
  • 2Ran C, Belin AC. The genetics of Parkinson' s disease : re- view of current and emerging candidates [J]. Journal of Parkinsonism and Restless Legs Syndrome, 2014(2014) : 63 - 75. 被引量:1
  • 3Lang AE. In pursuit of prodromal Parkinson~ disease [J]. The Lancet Neurology, 2015 ( 14 ) : 27 - 28. 被引量:1
  • 4Mounsey RB, Teismann P. Chelators in the treatment of Iron accumulationin Parkinson' s disease[J]. Internation- al Journal of Cell Biology, 2012 (2012) : e983245. 被引量:1
  • 5Youdim MB, GrnnblattE, Mandel S. The copper chelator, D-penicillamine, does not attenuate MPTP induced dopa- mine depletion in mice [J]. Journal of Neural Transmis- sion, 2007(2): 205 -209. 被引量:1
  • 6Forni GL, Balocco M, Cremonesi L, et al. Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation [J]. Movement disorders, 2008(6) :904 - 907. 被引量:1
  • 7Zorzi G, Zibordi F, Chiapparini L, et al. Iron-related MRI images in patients with pantothenate kinase-associat- ed neurodegeneration (PKAN) treated with deferiprone : Resuhs of a phase II pilot trial[J]. Movement Disorders, 2011(9) :1755 - 1759. 被引量:1
  • 8Jacoba F, Van Muiswinkel FL, Jongenelen CA, et al. The Neuroprotective antioxidant ot-lipoic acid induces detoxi- cation enzymes in cultured astroglial cells[J]. Free Radi- cal Research, 2010(6) : 695 -699. 被引量:1
  • 9Xu XJ, Wang QD, Zhan MM. Age, gender, and hemi- spheric differences in iron deposition in the human brain: An in vivo MRI study[J]. Neuro Image, 2008( 1 ) :35 - 42. 被引量:1
  • 10郭春彦,陈忻.铁与帕金森病关系研究进展[J].中国实验动物学报,2011,19(4). 被引量:10

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部